We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

Share Price Information for Inc&gwth Vct (IGV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 68.50
Ask: 71.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.38%)
Open: 70.00
High: 70.00
Low: 70.00
Prev. Close: 70.00
IGV Live PriceLast checked at -
The Income & Growth VCT is an Investment Trust

To provide an attractive return by maximising dividend distributions from the income and capital gains generated by investment in unquoted companies. This may include AIM companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

10 Jun 2020 15:00

RNS Number : 5576P
Income & Growth VCT (The) PLC
10 June 2020
 

THE INCOME & GROWTH VCT PLC

 

 

HALF-YEAR REPORT FOR THE SIX MONTHS ENDED 31 MARCH 2020

 

 

The Income & Growth VCT plc ("the Company") today announces the Half-Year results for the six months ended 31 March 2020.

 

 

As at 31 March 2020:

Net assets: £78.78 million

Net asset value ("NAV") per share: 68.46 pence

 

 

Net asset value ("NAV") total return per share fell by 7.8% for the six months.

Share price total return per share fell by 6.0% for the six months.

The Board has declared an interim dividend in respect of the current year of

3.00 pence per share to be paid to Shareholders on 10 July 2020.

The Company made four new investments totalling £4.15 million.

Proceeds of £8.36 million were received from investments realised, generating net realised gains of £2.53 million.

 

 

Performance summary

 

The table below shows the recent past performance of the Company's existing class of shares for each of the last five years, and the current year to date.

 

 

Reporting date

 

 

 

 

 

As at

Net assets

 

 

 

(£m)

NAV per

share

 

 

 

(p)

Share price1

 

 

 

(p)

Cumulative dividends paid per

share

 

(p)

Cumulative total return per share to Shareholders2

 

Dividends paid and proposed in respect of each year

(p)

 

NAV basis

(p)

Share price basis

(p)

 

 

31 March 2020

78.78

68.46

66.50

117.50

185.96

184.00

3.004

 

30 September 2019

81.73

79.12

75.503

113.00

192.12

188.50

6.00

 

30 September 2018

82.58

78.32

69.50

108.00

186.32

177.50

6.00

 

30 September 2017

64.35

81.24

73.00

102.50

183.74

175.50

21.00

 

30 September 2016

70.84

98.51

88.80

80.50

179.01

169.30

10.00

 

30 September 2015

75.20

106.38

93.50

68.50

174.88

162.00

12.00

 

1  Source: Panmure Gordon & Co (mid-market price).

2 Cumulative total return per share comprises the NAV per share (NAV basis) or the mid-market price per share (share price basis) plus cumulative dividends paid since launch of the current share class.

3  The share price at 30 September 2019 has been adjusted to add back the dividend of 4.50 pence per share paid on 18 October 2019, as the listed share price was quoted ex this dividend at the year end.

4  An interim dividend of 3.00 pence per share, referred to in the Financial Highlights above, is payable to Shareholders on 10 July 2020.

 

 

Chairman's Statement

I present the Company's Half-Year Report for the six months ended 31 March 2020 and extend a warm welcome to new Shareholders.

Overview

The Half-Year under review saw five months' strong progress being tempered by a very challenging final month for the portfolio as a result of the UK Government's lockdown and social distancing measures in response to the outbreak of COVID-19. These measures had an immediate adverse impact on UK businesses with many companies experiencing significant reduction in demand for their products and services, compounded by restrictions on their ability to operate.

 

The Board has liaised closely with the Investment Adviser, Mobeus Equity Partners LLP, who have been very actively engaged with the portfolio companies. The focus has been to ensure that all practical steps are being taken to enable each company to trade through the crisis where possible and to seek to grow value thereafter. The full impact of the COVID-19 crisis will only emerge as time passes. The immediate effect has been on the valuation of the portfolio as set out in detail in the Investment Adviser's Review and summarised in my Statement below.

 

During the period, the Company has realised three portfolio investments. Two of these were profitable exits of growth capital investments made since the VCT rule changes in 2015 (and the first such disposals for this portfolio category), and the third was the exit of Auction Technology Group, so becoming one of the Company's most successful investments to date. Also, four new investments were made into the portfolio, with two follow-on investments into existing portfolio companies made after the period end. Further details of this investment activity are contained in the Investment Adviser's Review.

 

Following the onset of the COVID-19 crisis, the Investment Adviser's focus has been to prioritise the funding requirements of the existing portfolio. A number of companies are continuing to experience significant growth and further investment is being made to capitalise on these opportunities. Other portfolio companies will continue to experience an adverse impact on their trading activities because of the crisis and may require further investment funding. The Company is well capitalised and will consider each case on merit should the need arise.

 

In the immediate term, the Company is adopting a cautious approach when considering new investment opportunities. Adequate depth of investment appraisal and due diligence is challenging during the current UK Government restrictions, business performance is highly volatile and achievement of forecasts more uncertain. However, looking further forward, the Board and Investment Adviser believe the investment landscape will become clearer and a number of attractive opportunities should be able to be brought forward.

 

Performance

The Company's NAV total return per share fell by 7.8% in the six months to 31 March 2020 (2019: increase of 4.1%), with the share price total return falling by 6.0% (2019: increase of 1.4%). Whilst disappointing, the Board believes that the Company's performance has demonstrated a degree of resilience in relation to its VCT peer group. This has been due to a number of factors which allow the Board to view the Company's future with cautious optimism over the medium to longer term.

 

These factors have been at both the portfolio and the fund level. The aggregate portfolio valuation decreased due to a number of reductions in the valuation of individual portfolio companies reflecting the impact of COVID-19. However, this adverse impact was partly offset by the benefit of the uplift achieved from the three profitable realisations in the period. In addition, several of the Company's investment structures afford a preference, such that a reduction in enterprise value does not feed directly into the same reduction in the value of the Company's investment. At the fund level, the Company has the benefit of significant liquidity and has therefore been cushioned to an extent from reductions in the valuations of invested assets. In addition, the Company's policy has been to invest its liquidity in lower risk liquidity funds and bank deposit accounts. This again has acted to mitigate the impact on the fund's overall value arising from falls in markets and valuations of invested assets.

 

The Company's cumulative NAV total return per share (being the closing net asset value plus total dividends paid to date) has decreased from 192.12 pence per share at the start of the period to 185.96 pence per share at the period end. This represents a decrease of 3.2% over the period.

 

Investment Portfolio

Following a detailed review by the Investment Adviser agreed by the Board, the portfolio has been valued 16.3% lower (2019: increase of 5.2%) compared to the value at the start of the period on a like-for-like basis. The portfolio carrying value has been reduced by £10.73 million of net unrealised losses, though there were net realised gains of £2.53 million arising from exits in the period. The portfolio was valued at £37.81 million at the period end (30 September 2019: £50.22 million).

 

During the six months under review, the Company invested a total of £4.15 million (2019: £2.00 million) into four (2019: four) new investments:

Active Navigation - A data analysis software provider

IPV - A media asset software provider

Bleach London - A hair care brand

Bella & Duke - A premium frozen raw dog food provider

 

After the period end, a total of £1.61 million was invested to support the further expansion of two existing portfolio companies:

MyTutor - A digital marketplace for school tutoring

Rotageek - A workforce management software provider

 

Details of this investment activity and the performance of the portfolio are contained in the Investment Review and the Investment Portfolio Summary within the Half-Year Report.

 

Revenue account

The results for the period are set out in the Unaudited Condensed Income Statement on pages 14 to 15 of the Half-Year Report and show a revenue return (after tax) of 1.40 pence per share (2019: 1.08 pence per share). The revenue return for the period of £1.53 million has increased from last year's comparable figure of £1.13 million. This is mainly due to higher loan stock income receivable arising from the realisation of Auction Technology Group.

 

As a result of COVID-19 related uncertainty upon their trading prospects, the Company has not recognised some interest due at 31 March 2020 as receivable in these accounts in respect of a higher number of investee companies than has previously been the case.

 

Dividends

The Board continues to be committed to providing an attractive dividend stream to Shareholders and is pleased to declare an Interim dividend of 3.00 pence per share for the year ending 30 September 2020, comprising 1.00 penny from income and 2.00 pence from capital.

 

This dividend will be paid on 10 July 2020 to Shareholders on the Register on 19 June 2020 and will bring cumulative dividends paid per share to 120.50 pence.

 

The Company's target of paying a dividend of at least 6.00 pence per share in respect of each financial year has been met or exceeded in each of the last eight years. I have previously noted that the gradual move of the portfolio to younger growth capital investments may make dividends harder to achieve from income and capital returns alone in any given year. Accordingly, the Board continues to monitor the sustainability of this target.

 

Dividend Investment Scheme

The Company's Dividend Investment Scheme was recommenced on 12 February 2020, having been temporarily suspended. All previously registered participants of the Scheme were automatically re-enrolled, with their future dividends to be re-invested unless they notified a wish to opt-out.

 

The Scheme provides Shareholders with the opportunity to reinvest their cash dividends into new shares in the VCT at the latest published NAV price (adjusted for subsequent dividends). New VCT shares attract the same tax reliefs as shares purchased through an offer for subscription.

 

Shareholders can opt-in by completing a mandate form available on the Company's website and can opt-out by contacting Link Asset Services, using their details provided under Shareholder Information on page 26 of the Half Year Report.

 

Fundraising

On 25 October 2019, the Company launched an offer for subscription of £5 million (the "Offer") with an over-allotment facility of an additional £5 million, alongside offers from the other Mobeus- advised VCTs.

 

I am pleased to report that the Offer experienced strong demand. The Board utilised the over-allotment facility of £5 million on 14 November 2019 and the Company received subscriptions in excess of the full amount sought of £10 million within two months of the launch date. In accordance with the Offer's prospectus, the allotment of shares under the Offer took place on 8 January 2020, in respect of the first £10 million of applications received and accepted. The Offer closed early, on 13 January 2020. The Board is grateful for this particularly strong level of support from both existing Shareholders and new investors.

 

Cash available for investment

The Board continues to monitor credit risk in respect of its cash balances and to prioritise the security and protection of the Company's capital. Cash and liquidity fund balances as at 31 March 2020 amounted to £40.89 million. This figure included £36.33 million held in money market funds with AAA credit ratings and £4.56 million held in deposit accounts with several well-known financial institutions across a range of maturities.

 

Share buy-backs

During the six months ended 31 March 2020, the Company bought back and cancelled 1,173,485 of its own shares, representing 1.1% (2019: 1.0%) of the shares in issue at the beginning of the period, at a total cost of £0.83 million (2019: £0.73 million), inclusive of expenses.

 

It is the Company's policy to cancel all shares bought back in this way. The Board regularly reviews its buyback policy, where its priority is to act prudently and in the interest of remaining Shareholders, whilst considering other factors, such as levels of liquidity and reserves, market conditions and applicable law and regulations. The current COVID-19 pandemic has contributed significantly to volatility in share prices generally. However, when buying back shares, the Company seeks to maintain the discount at which the Company's shares trade at no more than 5% below the latest published NAV.

 

Shareholder Communications

May I remind you that the Company has its own website which is available at: www.incomeandgrowthvct.co.uk

 

On behalf of all the Mobeus advised VCTs, the Investment Adviser held its most recent annual VCT Shareholder Event on 4 February 2020 which, from the feedback submitted, was well received by Shareholders. The event was held at The National Gallery in Central London and included presentations on the investment activity and performance of all the Mobeus VCTs. I would like to thank all those Shareholders who attended for helping to make it a success.

 

Environmental, Social and Governance

Your Board would like to assure Shareholders that it is taking these issues seriously, and future annual reports will be covering them in more detail. Further reporting and procedural requirements for these increasingly important issues required by current and future regulation should enable the Board to provide concise information and implement further processes, both relevant to the Company and, correspondingly, useful to stakeholders. These objectives do require that regulations are measured, proportionate and cost-effective to introduce.

 

Succession

During the period under review, the Company has appointed two new directors: Justin Ward who succeeded me as Chairman of both the Audit Committee and the Nomination and Remuneration Committee on 12 November 2019, and Maurice Helfgott, who was appointed on 12 February 2020.

 

The Board is continuing with its succession planning and, as announced on 12 February 2020, will be appointing Maurice Helfgott as its Chairman on 1 July 2020, following my retirement from the Board after 10 years, effective from 30 June 2020.

 

Both Maurice and Justin bring a wealth of experience to the Board and I would like to welcome them on behalf of all Shareholders.

 

Outlook

The impact of COVID-19 has been immediate and wide reaching. The eventual effects of the pandemic, many of which are unclear at present, are likely to be felt over the course of the months and years to come. Nevertheless, your Board considers that your Company is well positioned to cope with most likely scenarios in so far as they can presently be foreseen. The successful realisations and recent fundraising have given the Company strong liquidity not only to support the existing portfolio if appropriate, but also to capitalise on opportunities which may arise for new investment. The portfolio comprises a foundation of mature investments that are still providing an income return, as well as a younger, growth capital portfolio seeking to achieve scale, higher levels of profitability and hence value. The challenges arising from the COVID-19 pandemic should not be underestimated. However, once conditions stabilise, the Investment Adviser and the Board believe that a number of attractive new investment opportunities will emerge.

 

I would like to take this opportunity once again to thank all Shareholders for their continued support.

 

Jonathan Cartwright

Chairman

 

 

 

Investment Policy

The Company's policy is to invest primarily in a diverse portfolio of UK unquoted companies.

 

Asset Mix and Diversification

The Company will seek to make investments in UK unquoted companies in accordance with the prevailing requirements of VCT legislation.

 

Investments are made selectively across a wide variety of sectors, principally in established companies.

 

Investments are generally structured as part loan and part equity in order to receive regular income and to generate capital gain from realisations.

 

There are a number of conditions within the VCT legislation which need to be met by I&G and which may change from time to time.

 

 

No single investment may represent more than 15% (by VCT tax value) of the Company's total investments at the date of investment.

 

Save as set out above, the Company's other investments are held in cash and liquid funds.

 

Liquidity

The Company's cash and liquid funds are held in a portfolio of readily realisable interest bearing investments, deposit and current accounts, of varying maturities, subject to the overriding criterion that the risk of loss of capital be minimised.

 

Borrowing

The Company's articles of association permit borrowing of up to 10% of the adjusted capital and reserves (as defined therein). However, the Company has never borrowed and the Board would only consider doing to in exceptional circumstances.

 

 

 

Investment Adviser's Review

 

COVID-19 Pandemic

In March 2020, in response to the COVID-19 pandemic, the UK Government introduced lockdown and social distancing measures. These measures had an immediate adverse impact on UK businesses, with many companies experiencing significant reduction in consumer and business demand.

 

Businesses' ability to trade was further impacted by restrictions on their employees' working practices and disruption to their supply chains.

 

The travel, hospitality, leisure, consumer and physical retail sectors have seen the most significant adverse impact. On the other hand, there have been beneficiaries, including businesses in software and IT, online direct to consumer and those with long term business to business customers.

 

Many of the VCT's portfolio companies are encountering very challenging trading conditions, and the full extent and impact of COVID-19 will only emerge over time. The Investment Adviser, Mobeus, has reviewed and evaluated the impact of COVID-19 on each sector exposure and upon the value of the portfolio in so far as is practicable at the present time. Mobeus is fully engaged with the portfolio companies to ensure that all steps are being taken to assist each to trade through this crisis where possible, restore and grow value thereafter. As part of this, Mobeus is reviewing the implications for new and follow-on investments, with the recent fundraising and relatively high liquidity levels providing a solid foundation for such assessments.

 

Portfolio Review

Prior to the UK Government's response to the COVID-19 pandemic, the six months to 31 March 2020 had seen very positive progress within the portfolio. The Company invested a total of £4.15 million into four new growth capital investments, receiving net cash proceeds of £8.36 million, primarily from three very profitable realisations. Following the Investment Adviser's COVID-19 review, the valuation of each investee company has been considered, leading to an overall net valuation reduction of £10.73 million.

 

Activity in the six months to 31 March 2020 is summarised as follows:

2020

£m

2019

£m

Opening portfolio value

50.22

49.40

New and follow-on investments

4.15

2.00

Disposal proceeds

(8.36)

(2.29)

Net realised gains

2.53

0.37

Valuation movements

(10.73)

2.20

Portfolio value at 31 March

37.81

51.68

 

 

The investment and divestment activity during the period has increased the proportion of the portfolio in growth capital investments to 65.2% (2019: 47.9%) by value at the period end.

 

After the period end, the Company provided further investment totalling £1.61 million into two existing portfolio companies. This brings the total invested in growth capital investments made since the introduction of the new VCT regulations in 2015 to £26.28 million.

 

The portfolio's contribution to the overall results of the VCT is summarised below as follows:

 

Investment Portfolio

2020

2019

Capital Movement

£m

£m

Increase in the value of

1.71

4.68

unrealised investments

Decrease in the

(12.44)

(2.48)

value of unrealised

investments

Net (decrease)/

(10.73)

2.20

increase in the value of

unrealised investments

Realised gains

2.53

0.37

Realised losses

-

-

Net realised gains in

2.53

0.37

the period

Net investment

(8.20)

2.57

portfolio movement in

the period

 

Valuation changes of portfolio investments still held

The valuation reductions of £12.44 million principally arise from the Investment Adviser's COVID-19 impact review of the portfolio.

 

At summary level, there have been some clear beneficiaries of the COVID-19 crisis that are currently trading strongly.

 

Although some of the fillip will subside, there can be a reasonable expectation that some of the behavioural change will prove structural. Other businesses are raising capital to ensure that they are ready to capitalise on demand when it returns. The majority of the portfolio has experienced material impact but not sufficient to threaten their viability and/or require rescue financing. They have scaled back operations in response and are making full use of Government assistance schemes where appropriate. Finally, there are a few businesses whose viability is now under threat. In the main, these are businesses that were already struggling and hence the Company's carrying value had already been written down significantly. The value risk to the Company from this subset is therefore modest.

 

Within total valuation decreases, the main reductions were CGI Creative Graphics - £1.57 million, Media Business Insight - £1.35 million and Wetsuit Outlet - £1.02 million. These three companies saw some of the most significant impact of sudden decline in demand for their products or services. This was the prevailing impact across the portfolio, but some investee companies' trading has benefited from the lockdown, including Virgin Wines, Parsley Box, Bella & Duke, Bleach London and MyTutor.

 

Within total valuation increases, the principal contributors were Access IS £0.62 million and Active Navigation £0.44 million. The former valuation reflects the long-term nature of many of Access IS's projects, while the latter reflects the Company's preferred investment structure in Active Navigation.

 

Realised gains

Cash proceeds totalling £8.36 million have been received, principally from three realisations during the period under review.

 

In December, the Company realised £1.53 million from its first growth capital investment made under the new VCT rules, Redline Worldwide, generating a gain of £0.98 million in the period. Over the time that this investment was held, a multiple of 1.6x cost has been achieved to date with further proceeds potentially receivable in due course. £0.10 million of these proceeds was received in March, bringing the multiple on cost achieved to 1.7x.

 

In February, the Company exited investments held in Biosite and Auction Technology Group, generating a total realised gain in the period of £1.55 million. The investment in Biosite was realised, generating proceeds of £2.77 million over the life of the investment and contributed to a gain over original cost of 1.5x. Auction Technology Group generated proceeds over the life of the investment of £9.03 million compared to an original cost of £2.00 million, a multiple on cost of 4.5x over the 11 ½ years this investment was held - an exceptional return for Shareholders.

 

After the period end, a number of transactions occurred. A loan repayment of £0.09 million was received from BookingTek and, following continued under performance, the trade and assets of SuperCarers were sold to Home Instead for a nominal sum. Finally, following a significant increase in its share price, the Company received £0.64 million from the partial realisation of half its holding in Omega Diagnostics. This represented an attractive return of 4.6x multiple on cost and an IRR of 17.7%, securing a positive return overall whilst maintaining a degree of exposure to any potential upside.

 

Investment portfolio yield

In the period under review, the Company received the following amounts in interest and dividend income:

 

Investment Portfolio Yield

2020

2019

£m

£m

Interest received in the period

1.85

1.43

Dividends received in the period

0.35

0.24

Total portfolio income in the period1

2.20

1.67

Portfolio Value at 31 March

37.81

51.68

Portfolio Income Yield

(Income as a % of Portfolio value at 31 March)

5.8%

3.2%

1 Total portfolio income in the period is generated solely from investee companies within the portfolio.

 

The increase in income was due to interest of £1.09 million upon the loan instruments in Auction Technology Group being paid, as part of the sale transaction, which had not previously been recognised.

 

 

 

New investments in the Half-Year

The Company made four new investments totalling £4.15 million during the period, as detailed below:

 

 

Company

 

Business

 

Date of investment

 

Amount of new investment (£m)

 

 

Active Navigation

 

Data analysis software

 

November 2019

 

1.54

 

 

Data Discovery Solutions, trading as Active Navigation, is a data analysis software solution which makes it easier for companies to clean up network drives, respond to new data protection laws and dispose of redundant and out-dated documents. Active Navigation's solution is used by significant blue-chip customers, particularly those in highly regulated industries such as energy and professional services, as well as government entities in the USA, Canada, Australia and the UK. Active Navigation will seek to drive continued growth from its file analysis platform with the recruitment of experienced sales and professional services staff. Since 2014, revenues have grown from £1.50 million to £5.00 million in the its financial year to 30 June 2018.

 

 

IPV

 

Media asset software

 

November 2019

 

0.96

 

 

IPV has developed a media asset management software product called 'Curator'. This enables enterprise level customers to quickly retrieve and search hours of video footage, edit into multiple short clips and broadcast to online video platforms (such as YouTube) and company intranets. This enables IPV's impressive list of blue-chip clients such as Turner Sports, NASA and Sky, to improve efficiency in managing their video content. The company has built an impressive senior management team of proven operators and is targeting a media asset management market in the US and UK, worth an estimated £1 billion per annum. The investment will be used to build out a sales and marketing team and to fund lead generation for new direct and partner channels as well as supporting the existing partner network. From 2016 to 2018 recurring revenues grew over 50% annually and represented approximately 70% of total revenues in 2018.

 

 

Bleach London

 

Direct to consumer hair care brand

December 2019

 

0.72

 

 

 

Bleach London Holdings ("Bleach London") is an established branded, fast growing business which manufactures a range of haircare and colouring products. Bleach London is regarded as a leading authority in the hair colourant market having opened one of the world's first salons focused on colouring and subsequently launched its first range of products in 2013. The investment was part of a wider £5.60 million investment round alongside trade and angel investors. The funds will be used to drive continued growth in sales through retailers as well as capitalise on its strong social media presence whilst accelerating its growing direct to consumer channel. Bleach London delivered an impressive three times revenue growth between 2017 and 2018.

 

 

Bella & Duke

 

Premium frozen raw dog food provider

 

February 2020

 

0.93

 

 

Bella & Duke is a direct to consumer subscription service, providing premium frozen raw dog food to pet owners in the UK. Founded in 2016, the business provides an alternative to standard meal options for dog owners by focusing on the well documented health benefits of a raw food diet. This area is a growing niche in the large and established pet food market and is being driven by the premiumisation of dog food. The investment will seek to optimise its production and supply facilities, expand and enhance its team and broaden its product range. The company has grown revenues over 300% between 2018 and 2019.

 

 

Realisations during the Half-Year

The Company realised its investments in Redline, Biosite and Auction Technology Group as detailed below:

 

 

Company

 

Business

 

Period of investment

 

Total cash proceeds over the life of the investment/Multiple over cost

 

 

Redline

 

 

 

Provider of security services to the aviation industry and other sectors

February 2016 to December 2019

 

 

£1.95 million

1.7x cost

 

 

 

The Company sold its investment in Redline Worldwide for £1.53 million (realised gain in the period: £0.98 million) (including proceeds received after completion). Since investment in 2016, the investment has generated proceeds to date of £1.95 million compared to an original investment cost of £1.13 million, which is a multiple on cost to date of 1.7x and an IRR of 17.7%. Further proceeds may be receivable in due course.

 

 

Biosite

 

 

Workforce management and security services

 

November 2016 to February 2020

 

£2.77 million

1.5x cost

 

The Company sold its investment in Pattern Analytics Limited (trading as Biosite) to ASSA ABLOY for £2.65 million. Since investment in 2016, the investment has generated proceeds of £2.77 million compared to an original investment cost of £1.79 million, which is a multiple on cost of 1.5x and an IRR of 21.0%.

 

 

Auction Technology Group

 

SaaS based online auction marketplace platform

October 2008 to February 2020

 

£9.03 million

4.5x cost

 

 

The Company sold its investment in Turner Topco Limited (trading as Auction Technology Group) to TA Associates for £5.27 million (including £1.09 million loan interest due on completion; realised gain in the period: £1.55 million). This investment generated proceeds over the life of the investment of £9.03 million (including proceeds received following a partial realisation from a sale to ECI Partners in June 2014) compared to an original cost of £2.00 million, which is a multiple on cost of 4.5x and an IRR of 28.9%.

 

 

Finally, £0.003 million of liquidation proceeds have been received from H Realisations (2018) Limited (formerly Hemmels Limited).

 

 

Further investments made after the period end

The Company made two further investments into existing portfolio companies, totalling £1.61 million after the period end, as detailed below:

 

 

Company

 

Business

 

Period of investment

 

Total cash proceeds over the life of the investment/Multiple over cost

 

 

MyTutor

Digital Marketplace connecting school pupils seeking one-to-one online tutoring

May 2020

0.98

 

 

MyTutorWeb Limited (trading as "MyTutor") is a digital marketplace that connects school pupils who are seeking private one-to-one tutoring with university students. The business is satisfying a growing demand from both schools and parents to improve pupils' exam results to enhance their academic and career prospects. This further investment, alongside other existing shareholders, seeks to build and reinforce its position as a UK category leader in the online education market as well as to begin to develop a broader, personalised learning product offering. MyTutor has grown strongly over the last six months with average year on year growth of 70% and over 210,000 tutorials delivered in 2019. The COVID- 19 impact on the education sector has significantly heightened the awareness of online learning and tutoring.

 

 

Rotageek

Workforce management software

May 2020

0.63

 

 

Rota Geek Limited (trading as "Rotageek") is a provider of cloud-based enterprise software to help larger retail and leisure organisations predict and meet demand to schedule staff effectively. This investment, alongside funds from a new VCT investor and existing shareholders will be used to capitalise on opportunities that will emerge as the retail sector recovers from lockdown restrictions. Rotageek has also moved into healthcare to help address the workforce management issues of a sector that is chronically overburdened at present. For the year ended 31 December 2019, revenues have grown over 45% on the prior year.

 

 

 

After the period end, a number of transactions occurred. A loan repayment of £0.09 million was received from BookingTek and, following continued under performance, the trade and assets of SuperCarers were sold to Home Instead for a nominal sum. Finally, following a significant increase in its share price, the Company received £0.64 million from the partial realisation of half its holding in Omega Diagnostics. This represented an attractive return of 4.6x multiple on cost and an IRR of 17.7%, securing a positive return overall whilst maintaining a degree of exposure to any potential upside.

 

Mobeus Equity Partners LLP

Investment Adviser

 

 

Investment Portfolio Summary

 

Total cost at

Valuation at

Additional

Valuation at

31 March 2020

30 September 2019

investments

31 March 2020

(unaudited)

(audited)

in the period

(unaudited)

£

£

£

£

Tovey Management Limited (trading as Access IS)

3,313,932

4,144,573

-

4,764,862

Provider of data capture and scanning hardware

Virgin Wines Holding Company Limited

2,745,503

3,421,474

-

3,048,521

Online wine retailer

MPB Group Limited

2,043,137

3,858,515

-

3,009,661

Online marketplace for used photographic equipment

Preservica Limited

2,181,666

3,053,749

-

2,851,310

Seller of proprietary digital archiving software

EOTH Limited (trading as Equip Outdoor Technologies)

1,383,313

2,939,441

-

2,376,720

Distributor of branded outdoor equipment and clothing including the Rab and Lowe Alpine brands

Data Discovery Solutions Limited (trading as Active Navigation)

1,543,500

-

1,543,500

1,980,905

Provides the global market leading file analysis software for information governance, security and compliance

Proactive Group Holdings Inc

988,390

2,486,769

-

1,823,164

Media Services and investor conferences

MyTutorWeb Limited (trading as "MyTutor")

1,783,566

1,783,566

-

1,783,566

Digital marketplace connecting school pupils seeking one-to-one online tutoring

I-Dox plc

453,881

1,312,563

-

1,416,735

Developer and supplier of knowledge management products

Media Business Insight Holdings Limited

3,666,556

2,661,708

-

1,308,482

A publishing and events business focused on the creative production industries

Arkk Consulting Limited

1,526,007

1,546,354

-

1,274,590

Provider of services and software to enable organisations to remain compliant with regulatory reporting requirements

Vian Marketing Limited (trading as Red Paddle Co)

1,207,437

1,883,950

-

1,244,310

Design, manufacture and sale of stand-up paddleboards and windsurfing sails

Tharstern Group Limited

1,454,278

1,534,444

-

1,118,234

Software based management Information systems for the printing industry

Parsley Box Limited

925,800

925,800

-

1,102,716

Supplier of home delivered, ambient ready meals for the elderly

Buster and Punch Holdings Limited

725,226

1,176,202

-

976,365

Industrial inspired lighting and interiors retailer

IPV Limited

954,674

-

954,674

954,674

Provider of media asset software

Bella & Duke Limited

931,499

-

931,499

931,499

A premium frozen raw dog food provider

Bleach London Holdings Limited

721,452

-

721,452

909,403

An established direct to consumer brand in the hair colourants market

Rota Geek Limited

625,400

1,122,456

-

872,780

Workforce management software

Vectair Holdings Limited

53,400

935,546

-

821,819

Designer and distributor of washroom products

Ibericos Etc. Limited (trading as Tapas Revolution)

1,397,386

1,512,372

-

662,005

Spanish restaurant chain

Manufacturing Services Investment Limited

3,205,182

1,656,308

-

641,037

(trading as Wetsuit Outlet)

Online retailer in the water sports market

Bourn Bioscience Limited

1,610,379

349,376

-

531,425

Management of In-vitro fertilisation clinics

Kudos Innovations Limited

472,500

945,000

-

472,500

Online platform that provides and promotes academic research dissemination

CGI Creative Graphics International Limited

1,943,948

1,930,826

-

359,069

Vinyl graphics to global automotive, recreation vehicle and aerospace markets

Master Removers Group Limited (trading as Anthony Ward

464,658

1,196,408

-

233,412

Thomas, Bishopsgate and Aussie Man & Van)

A specialist logistics, storage and removals business

Omega Diagnostics Group plc

280,026

263,674

-

175,005

In-vitro diagnostics for food intolerance, autoimmune diseases

and infectious diseases

Blaze Signs Holdings Limited

418,281

599,314

-

147,257

Manufacturer and installer of signs

BG Training Limited

53,125

26,563

-

13,281

Technical training business

Corero Network Security plc

600,000

2,458

-

3,441

Provider of e-business technologies

RDL Corporation Limited

1,441,667

695,008

-

-

Recruitment consultants within the pharmaceutical, business

intelligence and IT industries

Aquasium Technology Limited

166,667

176,951

-

-

Manufacturing and marketing of bespoke electron beam welding

and vacuum furnace equipment

Jablite Holdings Limited

498,790

162,366

-

-

Manufacturer of expanded polystyrene products

BookingTek Limited

872,646

87,233

-

-

Software for hotel groups

Oxonica Limited

2,524,527

-

-

-

International nanomaterials group

Veritek Global Holdings Limited

2,289,859

-

-

-

Maintenance of imaging equipment

Racoon International Group Limited

655,851

-

-

-

Supplier of hair extensions, hair care products and training

Super Carers Limited

649,528

-

-

-

Online introductory platform connecting local individuals with

carers

NexxtDrive Limited/Nexxt E-drive Limited

487,014

-

-

-

Developer and exploiter of mechanical transmission technologies

CB Imports Group Limited (trading as Country Baskets)

175,000

-

-

-

Importer and distributor of artificial flowers, floral sundries and

home decor products

Biomer Technology Limited

137,170

-

-

-

Developer of biomaterials for medical devices

H Realisations (2018) Limited (formerly Hemmels Limited)

27,527

-

-

-

(in liquidation)

Sourcing and restoration of classic cars

Disposals in period

Pattern Analytics Limited (trading as Biosite)

-

2,648,952

-

-

Workforce management and security services for the construction

industry

Turner Topco Limited (trading as Auction Technology Group)

-

2,634,378

-

-

Publisher and online auction platform operator

Redline Worldwide Limited

-

550,430

-

-

Provider of security services to the aviation industry and other

sectors

Total

49,600,348

50,224,727

4,151,125

37,808,748

Total Investment Portfolio split by type

Growth focused portfolio

26,240,873

29,722,881

4,151,125

24,632,042

MBO focused portfolio

23,359,475

20,501,846

-

13,176,706

Total

49,600,348

50,224,727

4,151,125

37,808,748

 

 

Statement of Directors' Responsibilities

 

Responsibility statement

In accordance with Disclosure and Transparency Rule (DTR) 4.2.10, Jonathan Cartwright (Chairman), Maurice Helfgott, Justin Ward (Chairman of the Audit and Nomination & Remuneration Committees) and Helen Sinclair (Chairman of the Investment Committee), being the Directors of the Company, confirm that to the best of their knowledge:

 

(a) The condensed set of financial statements, which has been prepared in accordance with Financial Reporting Standard 104 "Interim Financial Reporting" gives a true and fair view of the assets, liabilities, financial position and profit of the Company as required by DTR 4.2.10;

 

(b) the Half-Year Management Report, which comprises the Chairman's Statement, Investment Policy, Investment Review and Investment Portfolio Summary, includes a fair review of the information required by DTR 4.2.7, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;

 

(c) a description of the principal risks and uncertainties facing the Company for the remaining six months is set out below, in accordance with DTR 4.2.7; and

 

(d) there were no related party transactions in the first six months of the current financial year that are required to be disclosed, in accordance with DTR 4.2.8.

 

 

Principal risks and uncertainties

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Financial Statements for the year ended 30 September 2019 ("the Annual Report"). The occurrence of the COVID-19 pandemic has created heighted uncertainty but has not changed the nature of the principal risks. The Board considers that the present processes for mitigating those risks remain appropriate.

 

The principal risks faced by the Company are:

 

Investment and liquidity

Loss of approval as a Venture Capital Trust;

Regulatory;

Economic and political;

Financial and operating;

Market liquidity;

 

A detailed explanation of the principal risks facing the Company can be found in the Annual Report on pages 27 and 28, and in Note 16 on Financial Instruments on pages 63 to 70. Copies can be viewed or downloaded from the Company's website: www.incomeandgrowthvct.co.uk

 

Going Concern

The Board has assessed the Company's operation as a going concern. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Half-Year Management Report. The Directors have satisfied themselves that the Company continues to maintain a significant cash position. The majority of companies in the portfolio are well funded and the portfolio taken as a whole remains resilient and well diversified.

 

The major cash outflows of the Company (namely investments, share buybacks and dividends) are within the Company's control. The Board's assessment of liquidity risk and details of the Company's policies for managing its capital and financial risks can be found in the Annual Report on pages 37 and 71, and in Note 16 on Financial Instruments on pages 63 to 70 of that Report. Accordingly, the Directors consider it appropriate to adopt the going concern basis of accounting in preparing the Financial Statements and the Directors' identification of any material uncertainties to the Company's ability to continue to do so over a period of at least twelve months from the date of approval of the Financial Statements.

 

Cautionary Statement

This report may contain forward looking statements with regards to the financial condition and results of the Company, which are made in the light of current economic and business circumstances. Nothing in this report should be construed as a profit forecast.

 

For and on behalf of the Board:

 

Jonathan Cartwright

Chairman

 

 

 

Unaudited Condensed Income Statement

for the six months ended 31 March 2020

 

Six months ended 31 March 2020

(unaudited)

Six months ended 31 March 2019

 (unaudited)

Notes

Revenue

Capital

Total

Revenue

Capital

Total

£

£

£

£

£

£

Net investment portfolio (losses)/gains

9

-

(8,201,658)

(8,201,658)

-

2,567,360

2,567,360

Income

4

2,311,854

-

2,311,854

1,783,886

-

1,783,886

Investment Adviser's fees

5

(236,541)

(709,625)

(946,166)

(215,882)

(647,647)

(863,529)

Other expenses

(270,947)

-

(270,947)

(224,094)

-

(224,094)

Profit/(loss) on ordinary activities before taxation

1,804,366

(8,911,283)

(7,106,917)

1,343,910

1,919,713

3,263,623

Tax on profit/(loss) on ordinary activities

6

(276,098)

276,098

-

(209,618)

209,618

-

Profit/(loss) for the period and total comprehensive income

1,528,268

(8,635,185)

(7,106,917)

1,134,292

2,129,331

3,263,623

Basic and diluted earnings per share

7

1.40p

(7.93)p

(6.53)p

1.08p

2.02p

3.10p

 

 

Year ended 30 September 2019

(audited)

 

Notes

Revenue

Capital

Total

 

£

£

£

 

Net investment portfolio (losses)/gains

-

4,932,113

4,932,113

 

Income

4

3,130,823

-

3,130,823

 

Investment Adviser's fees

5

(446,274)

(1,338,822)

(1,785,096)

 

Other expenses

(426,840)

-

(426,840)

 

 

Profit/(loss) on ordinary activities before taxation

2,257,709

3,593,291

5,851,000

 

Tax on profit/(loss) on ordinary activities

6

(381,993)

381,993

-

 

Profit/(loss) for the period and total comprehensive income

1,875,716

3,975,284

5,851,000

 

Basic and diluted earnings per share

7

1.80p

3.80p

5.60p

 

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the net investment portfolio unrealised (losses)/gains and realised gains on investments and the proportion of the Investment Adviser's fee and performance fee charged to capital.

 

The total column is the Statement of Total Comprehensive Income of the Company prepared in accordance with Financial Reporting Standards ("FRS"). In order to better reflect the activities of a VCT and in accordance with the 2014 Statement of Recommended Practice ("SORP") issued by the Association of Investment Companies ("AIC") and updated in October 2019, supplementary information which analyses the Income Statement between items of a revenue and capital nature has been presented alongside the Income Statement. The revenue column of profit attributable to equity Shareholders is the measure the Directors believe appropriate in assessing the Company's compliance with certain requirements set out in Section 274 Income Tax Act 2007.

 

All the items in the above statement derive from continuing operations of the Company. No operations were acquired or discontinued in the period/year.

 

The notes to the unaudited financial statements form part of these Half-Year Financial Statements.

 

 

Unaudited Condensed Balance Sheet

as at 31 March 2020

 

31 March 2020

31 March 2019

30 September 2019

(unaudited)

(unaudited)

(audited)

Fixed assets

Notes

£

£

£

Investments at fair value

9

37,808,748

51,682,001

50,224,727

Current assets

Debtors and prepayments

362,814

447,599

263,116

Current asset investments

10

39,479,736

27,873,883

29,964,187

Cash at bank

10

1,406,450

1,659,682

1,498,030

41,249,000

29,981,164

31,725,333

Creditors: amounts falling due within one year

(282,076)

(225,127)

(221,981)

Net current assets

40,966,924

29,756,037

31,503,352

 

Net assets

78,775,672

81,438,038

81,728,079

Capital and reserves

Called up share capital

1,150,685

1,043,639

1,033,029

Capital redemption reserve

16,980

44,235

5,245

Share premium reserve

9,625,433

46,473,760

-

Revaluation reserve

(6,814,985)

6,200,237

4,652,457

Special distributable reserve

61,740,118

18,486,621

63,751,255

Realised capital reserve

9,626,672

6,469,707

9,864,455

Revenue reserve

3,430,769

2,719,839

2,421,638

Equity Shareholders' funds

78,775,672

81,438,038

81,728,079

Basic and diluted net asset value:

Basic and diluted net asset value per share

11

68.46p

78.03p

79.12p

 

The financial information for the six months ended 31 March 2020 and the six months ended 31 March 2019 has not been audited.

 

The notes to the unaudited financial statements form part of these Half-Year Financial Statements.

 

 

Unaudited Condensed Statement of Changes in Equity

for the six months ended 31 March 2020

 

Non-distributable reserves

Distributable reserves

Called up

Capital

Share

Revaluation

Special

Realised

Revenue

Total

share

redemption

premium

reserve

distributable

capital

reserve

capital

reserve

reserve

reserve

reserve

(Note b)

(Note a)

(Note b)

£

£

£

£

£

£

£

£

At 1 October 2019

1,033,029

5,245

-

4,652,457

63,751,255

9,864,455

2,421,638

81,728,079

Comprehensive income

for the period

(Loss)/profit for the period

-

-

-

(10,733,344)

-

2,098,159

1,528,268

(7,106,917)

Total comprehensive

income for the period

-

-

-

(10,733,344)

-

2,098,159

1,528,268

(7,106,917)

Contributions by and

distributions to owners

Shares issued via Offer

for Subscription (Note c)

129,391

-

9,625,433

-

(99,106)

-

-

9,655,718

Shares bought

back (Note d)

(11,735)

11,735

-

-

(828,976)

-

-

(828,976)

Dividends paid

-

-

-

-

-

(4,153,095)

(519,137)

(4,672,232)

Total contributions by and

distributions to owners

117,656

11,735

9,625,433

-

(928,082)

(4,153,095)

(519,137)

4,154,510

Other movements

Realised losses transferred

to special reserve (Note a)

-

-

-

-

(1,083,055)

1,083,055

-

-

Realisation of previously

unrealised appreciation

-

-

-

(734,098)

-

734,098

-

-

Total other movements

-

-

-

(734,098)

(1,083,055)

1,817,153

-

-

At 31 March 2020

1,150,685

16,980

9,625,433

(6,814,985)

61,740,118

9,626,672

3,430,769

78,775,672

 

Notes

 

a): The Special distributable reserve also provides the Company with a reserve to absorb any existing and future realised losses and, when considered by the Board to be in the interests of Shareholders, to fund share buybacks and for other corporate purposes. As at 31 March 2020, the Company has a special reserve of £61,740,118, £33,576,818 of which relates to reserves from shares issued on or before 5 April 2014, or that arise from shares issued more than three years ago. Reserves originating from Share issues are not distributable under VCT rules if they are within three years of the end of an accounting period in which the shares were issued. The transfer of £1,083,055 to the special reserve from the realised capital reserve above is the total of realised losses incurred by the Company in the period.

 

b): The realised capital reserve and the revenue reserve together comprise the Profit and Loss Account of the Company.

 

c): Under the Company's Offer for Subscription launched on 25 October 2019, 12,939,080 ordinary shares were allotted on 8 January 2020, raising net funds of £9,655,718 for the Company. This figure is net of issue costs of £245,176.

 

d): During the period, the Company repurchased 1,173,485 of its own shares at the prevailing market price for a total cost (including stamp duty) of £828,976, which were subsequently cancelled. The difference between the figure above and that per the Statement of Cash Flows is £22,640, being an opening share buyback creditor of £40,379 offset by a share buyback creditor of £63,019 at the period end.

 

The notes to the unaudited financial statements form part of these Half-Year Financial Statements.

 

 

Unaudited Condensed Statement of Changes in Equity

for the six months ended 31 March 2019

 

Non-distributable reserves

Distributable reserves

Called up

Capital

Share

Revaluation

Special

Realised

Revenue

Total

share

redemption

premium

reserve

distributable

capital

reserve

capital

reserve

reserve

reserve

reserve

£

£

£

£

£

£

£

£

At 1 October 2018

1,054,384

33,490

46,473,760

4,102,002

19,655,855

8,627,792

2,636,431

82,583,714

Comprehensive income

for the period

Profit/(loss) for the period

-

-

-

2,199,709

-

(70,378)

1,134,292

3,263,623

Total comprehensive

income for the period

-

-

-

2,199,709

-

(70,378)

1,134,292

3,263,623

Contributions by and

distributions to owners

Shares bought back

(10,745)

10,745

-

-

(731,205)

-

-

(731,205)

Dividends paid

-

-

-

-

-

(2,627,210)

(1,050,884)

(3,678,094)

Total contributions by and

distributions to owners

(10,745)

10,745

-

-

(731,205)

(2,627,210)

(1,050,884)

(4,409,299)

Other movements

Realised losses transferred

to special reserve

-

-

-

-

(438,029)

438,029

-

-

Realisation of previously

unrealised appreciation

-

-

-

(101,474)

-

101,474

-

-

Total other movements

-

-

-

(101,474)

(438,029)

539,503

-

-

At 31 March 2019

1,043,639

44,235

46,473,760

6,200,237

18,486,621

6,469,707

2,719,839

81,438,038

The composition of each of these reserves is explained below:

 

Called up share capital - The nominal value of shares originally issued increased for subsequent share issues either via an Offer for Subscription or Dividend Investment Scheme or reduced due to shares bought back by the Company.

 

Capital redemption reserve - The nominal value of shares bought back and cancelled is held in this reserve, so that the Company's capital is maintained.

 

Share premium reserve - This reserve contains the excess of gross proceeds less issue costs over the nominal value of shares allotted under recent Offers for Subscription and the Company's Dividend Investment Scheme.

 

Revaluation reserve - Increases and decreases in the valuation of investments held at the period end are accounted for in this reserve, except to the extent that the diminution is deemed permanent.

 

In accordance with stating all investments at fair value through profit and loss, all such movements through both revaluation and realised capital reserves are shown within the Income Statement for the period.

 

Special distributable reserve - This reserve is created from cancellations of the balances upon the Share premium reserve, which are transferred to this reserve from time to time. The cost of share buybacks and any realised losses on the sale or impairment of investments (excluding transaction costs) are charged to this reserve. 75% of the Investment Adviser fee expense, and the related tax effect, that are charged to the realised capital reserve are transferred to this reserve. This reserve will also be charged any facilitation payments to financial advisers, which arose as part of the Offer for Subscription.

 

Realised capital reserve - The following are accounted for in this reserve:

 

• Gains and losses on realisation of investments;

• Permanent diminution in value of investments;

• Transaction costs incurred in the acquisition of investments;

 

• 75% of the Investment Adviser fee expense and 100% of any performance incentive fee payable, together with the related tax effect to this reserve in accordance with the policies; and

• Capital dividends paid.

 

Revenue reserve - Income and expenses that are revenue in nature are accounted for in this reserve together with the related tax effect, as well as income dividends paid that are classified as revenue in nature.

 

The notes to the unaudited financial statements form part of these Half-Year Financial Statements.

 

 

Unaudited Condensed Statement of Cash Flows

for the six months ended 31 March 2020

Six months ended 31 March 2020

Six months ended 31 March 2019

Year ended 30 September 2019

(unaudited)

(unaudited)

(audited)

Cash flows from operating activities

Notes

£

£

£

(Loss)/profit for the financial period

(7,106,917)

3,263,623

5,851,000

Adjustments for:

Net investment portfolio losses/(gains)

8,201,658

(2,567,360)

(4,932,113)

(Increase)/decrease in debtors

(80,341)

(66,947)

117,537

Increase/(decrease) in creditors and accruals

37,456

41,402

(2,124)

Net cash inflow from operating activities

1,051,856

670,718

1,034,300

Cash flows from investing activities

Purchase of investments

9

(4,151,125)

(1,933,990)

(5,004,960)

Disposal of investments

9

8,346,088

2,293,969

9,186,966

Net cash inflow from investing activities

4,194,963

359,979

4,182,006

Cash flows from financing activities

Shares issued as part of Offer for subscription

9,900,894

-

-

Issue costs as part of Offer for subscription

(245,176)

-

-

Equity dividends paid

8

(4,672,232)

(3,678,094)

(5,235,504)

Purchase of own shares

(806,336)

(731,205)

(1,430,752)

Net cash inflow/(outflow) from financing activities

4,177,150

(4,409,299)

(6,666,256)

Net increase/(decrease) in cash and cash equivalents

9,423,969

(3,378,602)

(1,449,950)

Cash and cash equivalents at start of period

28,310,448

29,760,398

29,760,398

Cash and cash equivalents at end of period

37,734,417

26,381,796

28,310,448

Cash and cash equivalents comprise:

Cash at bank and in hand

10

1,406,450

1,659,682

1,498,030

Cash equivalents

10

36,327,967

24,722,114

26,812,418

 

The notes to the unaudited financial statements form part of these Half-Year Financial Statements.

 

Notes to the Unaudited Condensed Financial Statements

for the six months ended 31 March 2020

 

1. Company information

 

The Income & Growth VCT plc is a public limited company incorporated in England, registration number 04069483. The registered office is 30 Haymarket, London, SW1Y 4EX.

 

2. Basis of preparation of the Financial Statements

 

These Financial Statements prepared in accordance with accounting policies consistent with Financial Reporting Standard 102 ("FRS102"), Financial Reporting Standard 104 ("FRS104") - Interim Financial Reporting, with the Companies Act 2006 and the 2014 Statement of Recommended practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('the SORP') (updated in October 2019) issued by the Association of Investment Companies.

 

The Half-Year Report has not been audited, nor has it been reviewed by the auditor pursuant to the Financial Reporting Council's (FRC) guidance on Review of Interim Financial Information.

 

3. Principal accounting policies

 

The accounting policies have been applied consistently throughout the period. Full details of principal accounting policies will be disclosed in the Annual Report, while the policy in respect of investments is included within an outlined box at the top of Note 9 on investments.

 

4. Income

 

Six months ended

Six months ended

Year ended

31 March 2020

31 March 2019

30 September 2019

(unaudited)

(unaudited)

(audited)

£

£

£

Income

- Dividends

351,220

240,656

259,666

- Money market funds

83,823

91,855

179,705

- Loan stock interest

1,851,961

1,408,515

2,623,375

- Bank deposit interest

24,570

23,074

48,292

- Interest on preference share dividend arrears

280

17,423

17,423

- Other income

-

2,363

2,362

Total Income

2,311,854

1,783,886

3,130,823

 

5. Investment Adviser's fees and performance fees

 

Six months ended 31 March 2020

Six months ended 31 March 2019

Year ended 30 September 2019

(unaudited)

(unaudited)

(audited)

£

£

£

Allocated to revenue return: Investment Adviser's fees

236,541

215,882

446,274

Allocated to capital return: Investment Adviser's fees

709,625

647,647

1,338,822

Investment Adviser's performance fees

-

-

-

Total

946,166

863,529

1,785,096

Investment Adviser's fee

946,166

863,529

1,785,096

Investment Adviser's performance fees

-

-

-

Total

946,166

863,529

1,785,906

The Directors have charged 75% of the fees payable under the Investment Adviser's agreement, and 100% of the amounts payable under the Incentive Agreements, to the capital reserve. The Directors believe it is appropriate to charge the incentive fees wholly against the capital return, as any fees payable depend on capital performance, as explained below.

 

On 30 September 2014, a new incentive fee agreement was signed between the Company and Mobeus, with effect from 1 October 2013, to amend and replace the previous agreement. The previous agreement remained in force, but only with the former adviser, Foresight Group LLP. Mobeus waived their right to their portion of the fee under the previous agreement. This agreement expired on 10 March 2019.

 

Any payment under the new incentive agreement is now 15% of net realised gains for each year, payable in cash. It is payable only if Cumulative Net Asset Value (NAV) total return per share (being the closing NAV at a year end plus cumulative dividends paid to that year end, since 1 October 2013) equals or exceeds a "Target Return". The Target Return is the greater of two targets, being either:

 

(i) compound growth of 6% per annum (but 5% per annum for the year ended 30 September 2014 only), before deducting any incentive fee payable (for the year of calculation only) under both this amended agreement and the existing incentive agreement with Foresight in Cumulative NAV total return per share; or

 

(ii) the cumulative percentage change in the Consumer Prices Index since 1 October 2013 to the relevant financial year end, the resultant figure then being multiplied by (100+A)/100, where A is the number of full 12 month periods (or part thereof ) that have passed between 1 October 2013 and the relevant financial year end.

 

Both measures of Target Return are applied to the same opening base, being NAV per share as at 30 September 2013 of

 

113.90 pence. The objective of this Target Return is to enable Shareholders to benefit from a cumulative NAV return of at least 6% per annum (5% in the financial year ended 30 September 2014), before any incentive fee is payable. Once a payment has been made, cumulative NAV total return is calculated after deducting past years' incentive fees paid and payable.

 

Under this new incentive agreement, any fee payments to Mobeus are subject to an annual cap of an amount equal to 2% of the net assets of the Company as at the immediately preceding year end. This cap included any fee payable to Foresight under the old agreement, although any such payment to Foresight was not capped, but that agreement expired on 10 March 2019. Any excess over the 2% remains payable to Mobeus in the following year(s), subject to the 2% annual cap in such subsequent year(s) and after any payment in respect of such subsequent year(s).

 

For the year ending 30 September 2020, the Target Return will be 169.65p per share (being a 6% uplift on the Target Return at the previous year end of 160.05 pence per share). As at 31 March 2020, the Cumulative Total NAV return is 145.46p per share, so the Target Return for the 2020 financial year has currently not been met and no fee has been accrued.

6. Taxation

 

There is no tax charge for the period as the Company has tax losses brought forward from previous periods, which can be offset against taxable income.

 

7. Basic and diluted earnings and return per share

 

Six months ended 31 March 2020

Six months ended 31 March 2019

Year ended 30 September 2019

(unaudited)

(unaudited)

(audited)

£

£

£

i) Total earnings after taxation:

(7,106,917)

3,263,623

5,851,000

Basic and diluted earnings per share (Note a)

(6.53)p

3.10p

5.60p

ii) Revenue earnings from ordinary activities after taxation

1,528,268

1,134,292

1,875,716

Basic and diluted revenue earnings per share (Note b)

1.40p

1.08p

1.80p

Net investment portfolio (losses)/gains

(8,201,658)

2,567,360

4,932,113

Capitalised Investment Adviser fees and performance fees less taxation

(433,527)

(438,029)

(956,829)

iii) Total capital return

(8,635,185)

2,129,331

3,975,284

Basic and diluted capital earnings per share (Note c)

(7.93)p

2.02p

3.80p

iv) Weighted average number of shares in issue in the period

108,874,052

105,141,805

104,575,505

Notes:

 

a) Basic earnings per share is total earnings after taxation divided by the weighted average number of shares in issue.

 

b) Basic revenue earnings per share is the revenue return after taxation divided by the weighted average number of shares in issue.

 

c) Basic capital earnings per share is the total capital return after taxation divided by the weighted average number of shares in issue.

 

d) There are no instruments that will increase the number of shares in issue in the future. Accordingly, the above figures currently represent both basic and diluted earnings per share.

 

8. Dividends

 

Dividend

Type

For the year ended 30 September

Pence

per

share

Date paid

Six months ended

Six months ended

Year ended

 

31 March 2020

31 March 2019

30 September 2019

 

(unaudited)

(unaudited)

(audited)

 

£

£

£

 

 

 

Final

Income

2018

1.00p

15 February 2019

-

1,050,884

1,049,870

 

Final

Capital

2018

2.50p

15 February 2019

-

2,627,210

2,624,676

 

Interim

Income

2019

1.00p

12 July 2019

-

-

1,040,639

 

Interim

Capital

2019

0.50p

12 July 2019

-

-

520,319

 

Interim

Income

2019

0.50p

18 October 2019

519,137

-

-

 

Interim

Capital

2019

4.00p

18 October 2019

4,153,095

-

-

 

 

Total

4,672,232

3,678,094

5,235,504

 

 

 

9. Summary of movement on investments during the period

 

The most critical estimates, assumptions and judgements relate to the determination of the carrying value of investments at 'fair value through profit and loss' ("FVTPL"). All investments held by the Company are classified as FVTPL and measured in accordance with the International Private Equity and Venture Capital Valuation ("IPEV") guidelines, as updated in December 2018. This classification is followed as the Company's business is to invest in financial assets with a view to profiting from their total return in the form of capital growth and income.

 

Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional. For investments actively traded on organised financial markets, fair value is generally determined by reference to Stock Exchange market quoted bid prices at the close of business on the balance sheet date. Purchases and sales of quoted investments are recognised on the trade date where a contract of sale exists whose terms require delivery within a time frame determined by the relevant market where the terms of a disposal state that consideration may be received at some future date and, subject to the conditionality and materiality of the amount of deferred consideration, an estimate of the fair value discounted for the time value of money may be recognised through the Income Statement. In other cases, the proceeds will only be recognised once the right to receive payment is established and there is no reasonable doubt that payment will be received.

 

Unquoted investments are stated at fair value by the Directors at each measurement date in accordance with appropriate valuation techniques, which are consistent with the IPEV guidelines:

 

(i) Each investment is considered as a whole on a 'unit of account' basis, i.e. that the value of each portfolio company is considered as a whole, alongside consideration of:-

 

The price of new investments made, if deemed to be made as part of an orderly transaction, are considered to be at fair value at the date of the transaction. The inputs that derived the investment price are calibrated within individual valuation models and at subsequent measurement dates, are reconsidered for any changes in light of more recent events or changes in light of more recent events or changes in the market performance of the investee company. The valuation bases used are the following:

 

a) a multiple basis. The investment may be valued by applying a suitable price-earnings ratio, revenue or gross profit multiple to that company's historic, current or forecast post-tax earnings before interest and amortisation, or revenue, or gross profit in order to derive an enterprise value (the ratio used being based on a comparable sector but the resulting value being adjusted to reflect points of difference identified by the Investment Adviser compared to the sector including, inter alia, a lack of marketability).

 

 

or:-

 

b) where a company's underperformance against plan indicates a diminution in the value of the investment, provision against cost is made, as appropriate.

 

(ii) Premiums, to the extent that they are considered capital in nature, and that they will be received upon repayment of loan stock investments are accrued at fair value when the Company receives the right to the premium and when considered recoverable.

 

(iii) Where a multiple or the price of recent investment less impairment basis is not appropriate and overriding factors apply, a discounted cash flow, net asset valuation, realisation proceeds or, a weighted average of these bases may be applied.

 

Capital gains and losses on investments, whether realised or unrealised, are dealt with in the profit and loss and revaluation reserves and movements in the period are shown in the Income Statement.

 

All investments are initially recognised and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.

 

A key judgement made in applying the above accounting policy relates to investments that are permanently impaired. Where the value of an investment has fallen permanently below cost, the loss is treated as a permanent impairment and as a realised loss, even though the investment is still held. The Board assesses the portfolio for such investments and, after agreement with the Investment Adviser, will agree the values that represent the extent to which an investment loss has become realised. This is based upon an assessment of objective evidence of that investment's future prospects, to determine whether there is potential for the investment to recover in value.

 

The methods of fair value measurement are classified into hierarchy based on the reliability of the information used to determine the valuation.

 

- Level 1 - Fair value is measured based on quoted prices in an active market.

 

- Level 2 - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices.

 

- Level 3 - Fair value is measured using valuation techniques using inputs that are not based on observable market data.

Traded

Unquoted

Unquoted

Unquoted

Total

on AIM

ordinary

Preference

Loan stock

shares

shares

Level 1

Level 3

Level 3

Level 3

£

£

£

£

£

Valuation at 1 October 2019

1,578,695

25,772,163

19,247

22,854,622

50,224,727

Purchases at cost

-

4,151,125

-

-

4,151,125

Sales - proceeds (Note a)

-

(4,860,994)

-

(3,504,452)

(8,365,446)

Net realised gains

-

2,037,191

-

494,495

2,531,686

Net unrealised gains/(losses) on investments

16,486

(5,598,457)

2,473

(5,153,846)

(10,733,344)

Valuation at 31 March 2020

1,595,181

21,501,028

21,720

14,690,819

37,808,748

Book cost at 31 March 2020

1,333,907

28,082,929

24,138

20,159,374

49,600,348

Unrealised gains/(losses) at 31 March 2020

761,274

(2,220,000)

(2,418)

(5,353,841)

(6,814,985)

Permanent impairment of valuation of investments

(500,000)

(4,361,901)

-

(114,714)

(4,976,615)

Valuation at 31 March 2020

1,595,181

21,501,028

21,720

14,690,819

37,808,748

Gains/(losses) on investments

Realised gains based on historical cost

-

2,987,446

-

278,338

3,265,784

Less amounts recognised as unrealised

(gains)/losses in previous years

-

(950,255)

-

216,157

(734,098)

Net realised gains based on carrying

value at 30 September 2019

-

2,037,191

-

494,495

2,531,686

Net movement in unrealised gains/

(losses) in the period

16,486

(5,598,457)

2,473

(5,153,846)

(10,733,344)

Net investment portfolio gains/(losses)

for the period ended 31 March 2020

16,486

(3,561,266)

2,473

(4,659,351)

(8,201,658)

Notes

 

a): The sale proceeds shown above of £8,365,446 is £19,358 more than that shown on the Statement of Cash Flows of £8,346,088 due to further proceeds receivable in respect of Redline. This amount is recognised as a debtor at 31 March 2020.

 

There has been no significant change in the risk analysis as disclosed in Note 18 of the Financial Statements in the Company's Annual Report. The decrease in unrealised valuations of the loan stock investments above reflect the changes in the entitlement to loan premiums, and/or in the underlying enterprise value of the investee company. The decrease does not arise from assessments of credit or market risk upon these instruments.

 

10. Current asset investments and Cash at bank

as at

as at

as at

31 March 2020

31 March 2019 30 September 2019

(unaudited)

(unaudited)

(audited)

£

£

£

OEIC Money market funds

36,327,967

24,722,114

26,812,418

Cash equivalents per Statement of Cash Flows

36,327,967

24,722,114

26,812,418

Bank deposits that mature after three months

3,151,769

3,151,769

3,151,769

Current asset investments

39,479,736

27,873,883

29,964,187

Cash at bank

1,406,450

1,659,682

1,498,030

11. Net asset value per share

 

as at

as at

as at

31 March 2020

31 March 2019 30 September 2019

(unaudited)

(unaudited)

(audited)

Net assets

£78,775,672

£81,438,038

£81,728,079

Number of shares in issue

115,068,452

104,363,865

103,302,857

Net asset value per share - basic and diluted

68.46p

78.03p

79.12p

 

12. Post balance sheet events

On 30 April 2020, proceeds of £644,835 were received in respect of a partial realisation of Omega Diagnostics plc.

 

On 5 May 2020, a further £625,400 was invested into Rotageek and a further £975,770 was invested on 26 May 2020 into MyTutor, both existing portfolio companies.

 

On 19 May 2020, the Company received £90,375 as a loan repayment from BookingTek Limited.

 

13. Statutory Information

 

The financial information for the six months ended 31 March 2020 and the six months ended 31 March 2019 has not been audited.

 

The financial information contained in this Half-Year Report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The financial statements for the year ended 30 September 2019 have been filed with the Registrar of Companies. The auditor has reported on these Financial Statements and that report was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

 

14. Half-Year Report

 

Copies of this statement are being sent to all Shareholders. Further copies are available free of charge from the Company's registered office, 30 Haymarket, London, SW1Y 4EX, or can be downloaded via the Company's website at www.incomeandgrowthvct.co.uk, under the heading Key Shareholder Information on the left-hand side.

 

Contact details for further enquiries:

Mobeus Equity Partners LLP (the Company Secretary) on 020 7024 7600 or by e-mail to vcts@mobeus.co.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR FBLFFBQLLBBB
Date   Source Headline
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
29th Feb 20242:00 pmRNSResult of Annual General Meeting
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
27th Feb 20249:30 amRNSInterim Management Statement
1st Feb 202411:35 amRNSVoting Rights and Capital
22nd Jan 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20249:04 amRNSAnnual Financial Report
2nd Jan 20242:30 pmRNSVoting Rights and Capital
1st Dec 20237:00 amRNSTotal Voting Rights
8th Nov 202310:20 amRNSDirector/PDMR Shareholding
8th Nov 202310:15 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSTransaction in Own Shares
25th Sep 202311:00 amRNSDividend Declaration
20th Sep 20233:30 pmRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:02 pmRNSTransaction in Own Shares
14th Jun 20237:00 amRNSHalf-year Report
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20235:15 pmRNSDirector/PDMR Shareholding
26th May 20235:00 pmRNSIssue of Equity and Total Voting Rights
26th May 20234:36 pmRNSNet Asset Value(s)
2nd May 202310:00 amRNSTotal Voting Rights
13th Apr 20231:00 pmRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202311:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment:Tharstern Group Limited
3rd Mar 20235:04 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:30 pmRNSInterim Management Statement
22nd Feb 20233:15 pmRNSResult of AGM
7th Feb 20237:01 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:14 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:34 pmRNSTransaction in Own Shares
19th Dec 20227:00 amRNSAnnual Financial Report
13th Dec 20223:47 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.